Cargando…

Amide-containing neoepitopes: the key factor in the preparation of hapten-specific antibodies and a strategy to overcome

For a long time, people have suffered from uncertainty, complexity, and a low success rate in generating and screening antibodies against small molecules, which have become the core bottlenecks of immunochemistry. Here, the influence of antigen preparation on antibody generation was investigated at...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xiangning, Lin, Hong, Chen, Xiangfeng, Wang, Luefeng, Zhang, Ziang, Wei, Xiaojing, Sun, Xun, Xie, Hanyi, Pavase, Tushar Ramesh, Cao, Limin, Sui, Jianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277511/
https://www.ncbi.nlm.nih.gov/pubmed/37342337
http://dx.doi.org/10.3389/fimmu.2023.1144020
_version_ 1785060298164535296
author Han, Xiangning
Lin, Hong
Chen, Xiangfeng
Wang, Luefeng
Zhang, Ziang
Wei, Xiaojing
Sun, Xun
Xie, Hanyi
Pavase, Tushar Ramesh
Cao, Limin
Sui, Jianxin
author_facet Han, Xiangning
Lin, Hong
Chen, Xiangfeng
Wang, Luefeng
Zhang, Ziang
Wei, Xiaojing
Sun, Xun
Xie, Hanyi
Pavase, Tushar Ramesh
Cao, Limin
Sui, Jianxin
author_sort Han, Xiangning
collection PubMed
description For a long time, people have suffered from uncertainty, complexity, and a low success rate in generating and screening antibodies against small molecules, which have become the core bottlenecks of immunochemistry. Here, the influence of antigen preparation on antibody generation was investigated at both molecular and submolecular levels. Neoepitopes (amide-containing neoepitopes) formed in the preparation of complete antigens are one of the most important factors limiting the efficiency of generating hapten-specific antibodies, which was verified by different haptens, carrier proteins, and conjugation conditions. Amide-containing neoepitopes present electron-dense structural components on the surface of prepared complete antigens and, therefore, induce the generation of the corresponding antibody with much higher efficiency than target hapten. Crosslinkers should be carefully selected and not overdosed. According to these results, some misconceptions in the conventional anti-hapten antibody production were clarified and corrected. By controlling the content of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) during the synthesis of immunogen to limit the formation of amide-containing neoepitopes, the efficiency of hapten-specific antibody generation could be significantly improved, which verified the correctness of the conclusion and provided an efficient strategy for antibody preparation. The result of the work is of scientific significance in the preparation of high-quality antibodies against small molecules.
format Online
Article
Text
id pubmed-10277511
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102775112023-06-20 Amide-containing neoepitopes: the key factor in the preparation of hapten-specific antibodies and a strategy to overcome Han, Xiangning Lin, Hong Chen, Xiangfeng Wang, Luefeng Zhang, Ziang Wei, Xiaojing Sun, Xun Xie, Hanyi Pavase, Tushar Ramesh Cao, Limin Sui, Jianxin Front Immunol Immunology For a long time, people have suffered from uncertainty, complexity, and a low success rate in generating and screening antibodies against small molecules, which have become the core bottlenecks of immunochemistry. Here, the influence of antigen preparation on antibody generation was investigated at both molecular and submolecular levels. Neoepitopes (amide-containing neoepitopes) formed in the preparation of complete antigens are one of the most important factors limiting the efficiency of generating hapten-specific antibodies, which was verified by different haptens, carrier proteins, and conjugation conditions. Amide-containing neoepitopes present electron-dense structural components on the surface of prepared complete antigens and, therefore, induce the generation of the corresponding antibody with much higher efficiency than target hapten. Crosslinkers should be carefully selected and not overdosed. According to these results, some misconceptions in the conventional anti-hapten antibody production were clarified and corrected. By controlling the content of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) during the synthesis of immunogen to limit the formation of amide-containing neoepitopes, the efficiency of hapten-specific antibody generation could be significantly improved, which verified the correctness of the conclusion and provided an efficient strategy for antibody preparation. The result of the work is of scientific significance in the preparation of high-quality antibodies against small molecules. Frontiers Media S.A. 2023-06-05 /pmc/articles/PMC10277511/ /pubmed/37342337 http://dx.doi.org/10.3389/fimmu.2023.1144020 Text en Copyright © 2023 Han, Lin, Chen, Wang, Zhang, Wei, Sun, Xie, Pavase, Cao and Sui https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Han, Xiangning
Lin, Hong
Chen, Xiangfeng
Wang, Luefeng
Zhang, Ziang
Wei, Xiaojing
Sun, Xun
Xie, Hanyi
Pavase, Tushar Ramesh
Cao, Limin
Sui, Jianxin
Amide-containing neoepitopes: the key factor in the preparation of hapten-specific antibodies and a strategy to overcome
title Amide-containing neoepitopes: the key factor in the preparation of hapten-specific antibodies and a strategy to overcome
title_full Amide-containing neoepitopes: the key factor in the preparation of hapten-specific antibodies and a strategy to overcome
title_fullStr Amide-containing neoepitopes: the key factor in the preparation of hapten-specific antibodies and a strategy to overcome
title_full_unstemmed Amide-containing neoepitopes: the key factor in the preparation of hapten-specific antibodies and a strategy to overcome
title_short Amide-containing neoepitopes: the key factor in the preparation of hapten-specific antibodies and a strategy to overcome
title_sort amide-containing neoepitopes: the key factor in the preparation of hapten-specific antibodies and a strategy to overcome
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277511/
https://www.ncbi.nlm.nih.gov/pubmed/37342337
http://dx.doi.org/10.3389/fimmu.2023.1144020
work_keys_str_mv AT hanxiangning amidecontainingneoepitopesthekeyfactorinthepreparationofhaptenspecificantibodiesandastrategytoovercome
AT linhong amidecontainingneoepitopesthekeyfactorinthepreparationofhaptenspecificantibodiesandastrategytoovercome
AT chenxiangfeng amidecontainingneoepitopesthekeyfactorinthepreparationofhaptenspecificantibodiesandastrategytoovercome
AT wangluefeng amidecontainingneoepitopesthekeyfactorinthepreparationofhaptenspecificantibodiesandastrategytoovercome
AT zhangziang amidecontainingneoepitopesthekeyfactorinthepreparationofhaptenspecificantibodiesandastrategytoovercome
AT weixiaojing amidecontainingneoepitopesthekeyfactorinthepreparationofhaptenspecificantibodiesandastrategytoovercome
AT sunxun amidecontainingneoepitopesthekeyfactorinthepreparationofhaptenspecificantibodiesandastrategytoovercome
AT xiehanyi amidecontainingneoepitopesthekeyfactorinthepreparationofhaptenspecificantibodiesandastrategytoovercome
AT pavasetusharramesh amidecontainingneoepitopesthekeyfactorinthepreparationofhaptenspecificantibodiesandastrategytoovercome
AT caolimin amidecontainingneoepitopesthekeyfactorinthepreparationofhaptenspecificantibodiesandastrategytoovercome
AT suijianxin amidecontainingneoepitopesthekeyfactorinthepreparationofhaptenspecificantibodiesandastrategytoovercome